HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas A Burke Selected Research

rofecoxib (Vioxx)

2/2004Longer use of COX-2-specific inhibitors compared to nonspecific nonsteroidal antiinflammatory drugs: a longitudinal study of 3639 patients in community practice.
2/2003A model analysis of costs of blood pressure destabilization and edema associated with rofecoxib and celecoxib among older patients with osteoarthritis and hypertension in a Medicare Choice population.
10/2002Blood pressure destabilization and related healthcare utilization among hypertensive patients using nonspecific NSAIDs and COX-2-specific inhibitors.
10/2002Cost of heart failure among hypertensive users of nonspecific NSAIDs and COX-2-specific inhibitors.
6/2002Physician-reported management of edema and destabilized blood pressure in cyclooxygenase-2-specific inhibitor users with osteoarthritis and treated hypertension.
5/2002Increase in lifetime adverse drug reactions, service utilization, and disease severity among patients who will start COX-2 specific inhibitors: quantitative assessment of channeling bias and confounding by indication in 6689 patients with rheumatoid arthritis and osteoarthritis.
3/2002Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thomas A Burke Research Topics

Disease

10Vomiting
01/2016 - 12/2006
10Nausea
01/2016 - 12/2006
7Neoplasms (Cancer)
01/2015 - 04/2004
7Hypertension (High Blood Pressure)
09/2007 - 06/2002
5Osteoarthritis
05/2004 - 05/2002
3Type 2 Diabetes Mellitus (MODY)
05/2006 - 05/2005
3Rheumatoid Arthritis
05/2004 - 05/2002
2Stroke (Strokes)
12/2005 - 07/2005
2Chronic Kidney Failure (Chronic Renal Failure)
10/2005 - 05/2005
2Diabetic Nephropathies (Diabetic Nephropathy)
10/2005 - 05/2005
2Edema (Dropsy)
02/2003 - 06/2002
2Heart Failure
10/2002 - 10/2002
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019
1Hepatitis
09/2012
1Chronic Hepatitis B
09/2012
1Malaria
05/2011
1Foodborne Diseases
11/2009
1Acquired Immunodeficiency Syndrome (AIDS)
02/2009
1Mycoses (Diseases, Fungus)
02/2009
1Neutropenia
02/2009
1Diabetes Mellitus
09/2007
1Cardiovascular Diseases (Cardiovascular Disease)
12/2005
1Atherosclerosis
12/2005
1Peripheral Arterial Disease
12/2005
1Coronary Disease (Coronary Heart Disease)
12/2005
1Myocardial Infarction
07/2005
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
07/2005
1Essential Hypertension
07/2005
1Migraine Disorders (Migraine)
11/2004
1Fibromyalgia (Fibrositis)
02/2004
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
10/2002
1Heart Diseases (Heart Disease)
10/2002
1Myocardial Ischemia (Ischemic Heart Diseases)
10/2002
1Rheumatic Diseases (Rheumatism)
05/2002
1Stomach Ulcer (Gastric Ulcer)
03/2002
1Ulcer
03/2002
1Dyspepsia (Indigestion)
01/2002

Drug/Important Bio-Agent (IBA)

7Celecoxib (Celebrex)FDA Link
02/2004 - 03/2002
7rofecoxib (Vioxx)FDA Link
02/2004 - 03/2002
6Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
05/2004 - 01/2002
5AntiemeticsIBA
01/2016 - 01/2014
3Pharmaceutical PreparationsIBA
05/2011 - 03/2002
3Antihypertensive Agents (Antihypertensives)IBA
09/2007 - 10/2005
3Losartan (Cozaar)FDA LinkGeneric
10/2005 - 05/2005
3Ibuprofen (Motrin)FDA LinkGeneric
02/2004 - 10/2002
3Naproxen (Naprosyn)FDA LinkGeneric
02/2004 - 10/2002
2ArsenicIBA
05/2006 - 12/2005
2Angiotensin IIIBA
10/2005 - 05/2005
2Diclofenac (SR 38)FDA LinkGeneric
10/2002 - 10/2002
1pembrolizumabIBA
01/2019
1MercuryIBA
09/2012
1Biomarkers (Surrogate Marker)IBA
09/2012
1Antimalarials (Antimalarial Agents)IBA
05/2011
1Drinking WaterIBA
11/2009
1Micafungin (FK463)FDA Link
02/2009
1EchinocandinsIBA
02/2009
1Drug CombinationsIBA
09/2007
1CreatinineIBA
10/2005
1Atenolol (Tenormin)FDA LinkGeneric
07/2005
1rizatriptan (Maxalt)FDA Link
11/2004
1Environmental Pollutants (Pollutants, Environmental)IBA
04/2004
1DiureticsIBA
06/2002
1Antirheumatic Agents (DMARD)IBA
05/2002
1Sucralfate (Carafate)FDA LinkGeneric
03/2002
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
03/2002
1Proton Pump InhibitorsIBA
03/2002
1Misoprostol (Cytotec)FDA LinkGeneric
03/2002

Therapy/Procedure

12Drug Therapy (Chemotherapy)
01/2019 - 07/2005
9Therapeutics
01/2015 - 01/2002
1Drug Prescriptions
09/2007
1Drug Substitution
05/2004